Youth-onset type 2 diabetes in Israel: A national cohort

Nehama Zuckerman Levin, Meidan Cohen, Moshe Phillip, Ariel Tenenbaum, Ilana Koren, Yardena Tenenbaum-Rakover, Osnat Admoni, Eli Hershkovitz, Alon Haim, Kineret Mazor Aronovitch, David Zangen, David Strich, Avivit Brener, Yonatan Yeshayahu, Yossi Schon, Marianna Rachmiel, Tal Ben-Ari, Floris Levy-Khademi, Rami Tibi, Ram WeissYael Lebenthal, Orit Pinhas-Hamiel, Naim Shehadeh

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Prevalence of youth-onset type 2 diabetes (T2D) has increased worldwide, paralleling the rise in pediatric obesity. Occurrence and clinical manifestations vary regionally and demographically. Objectives: We assessed the incidence, and clinical and demographic manifestations of youth-onset T2D in Israel. Methods: In a national observational study, demographic, clinical, and laboratory data were collected from the medical records of children and adolescents, aged 10–18 years, diagnosed with T2D between the years 2008 and 2019. Results: The incidence of youth-onset T2D in Israel increased significantly from 0.63/100,000 in 2008 to 3.41/100,000 in 2019. The study cohort comprised 379 individuals (228 girls [59.7%], 221 Jews [58.3%], mean age 14.7 ± 1.9 years); 73.1% had a positive family history of T2D. Mean body mass index (BMI) z-score was 1.96 ± 0.7, higher in Jews than Arabs. High systolic (≥ 130 mmHg) and diastolic blood pressure (≥ 85 mmHg) were observed in 33.7% and 7.8% of patients, respectively; mean glycosylated hemoglobin (A1c) level at diagnosis was 8.8 ± 2.5%. Dyslipidemia, with high triglyceride (>150 mg/dl) and low HDL-c (<40 mg/dl) levels, was found in 45.6% and 56.5%, respectively. Microalbuminuria and retinopathy were documented at diagnosis, 15.2% and 1.9%, respectively) and increased (36.7% and 4.6%, respectively) at follow-up of 2.9 ± 2.1 years. Criteria of metabolic syndrome were met by 224 (62.2%) patients, and fatty liver documented in 65%, mainly Jews. Psychosocial comorbidity was found in 31%. Treatment with metformin (45.6%), insulin (20.6%), and lifestyle modification (18%) improved glycemic control. Conclusion: Youth-onset T2D in Israel has increased significantly and presents a unique profile.

Original languageEnglish
Pages (from-to)649-659
Number of pages11
JournalPediatric Diabetes
Volume23
Issue number6
DOIs
StatePublished - Sep 2022

Keywords

  • children and adolescents
  • ethnicity
  • metabolic syndrome
  • obesity
  • youth-onset type 2 diabetes

Fingerprint

Dive into the research topics of 'Youth-onset type 2 diabetes in Israel: A national cohort'. Together they form a unique fingerprint.

Cite this